Skip to main content
Log in

Clinical tolerability of ibopamine hydrochloride (SB 7505)

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The clinical tolerance of ibopamine hydrochloride (SB 7505) was investigated in 12 volunteers. The drug was administered on alternate days (2nd, 4th, 6th, 8th, 10th, 12th), starting at 100 mg and increasing by 50 mg each time to reach 350 mg on the 12th day. On the other days (1st, 3rd, 5th, 7th, 9th, 11th and 13th) a placebo was given. Diuresis increased progressively with the dose, reaching a maximum increase of 88% after the last dose, and showing a small residual effect on each subsequent placebo day. Body weight showed a marginal change and decreased by 2% in the last two days of treatment. Heart rate, systolic, diastolic and mean blood pressure showed only marginal fluctuations of about 7% around the mean values, which were of little statistical and of no clinical significance.

Haematological and biochemical parameters were not affected. No side effect was noticed. The dose of 350 mg may probably be increased without leading to side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Melloni GF, Minoja GM, Scarazzati G, Bauer R, Brusoni B, Ghirardi P (1981) Renal effects of SB 7505: A double-blind study. Eur J Clin Pharmacol 19: 177–180

    Google Scholar 

  • Merlo L, Brusoni B, Ghirardi P (1979) Effetti dell'Estere Diisobutirrico dell'N-Metil-Dopamina (SB 7505) sull'emodinamica del distretto renale e sulla contrattilità del miocardio del cane narcotizzato. Atti XL Congresso Soc. Ital. di Cardiol.

  • Ghirardi P, Bauer R, Brusoni B (1980) Effects d'un dérivé de la dopamine actif par voie orale sur l'excrétion rénale. Nouv Presse Méd 9: 453

    Google Scholar 

  • Dei Cas L, Manca C, Vasini G, Mansour M, Bernardini B, Visioli O (1980) Non-invasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneim.-Forsch 30: 498–500

    Google Scholar 

  • Stefoni S, Colì L, Mosconi G, Prandini R (1981) Ibopamine (SB 7505) in normal subjects and in chronic renal failure A preliminary report. Br J Clin Pharmacol 1: 69–72

    Google Scholar 

  • Draper N, Smith H (1966) Applied regression analysis. J. Wiley, London

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melloni, G.F., Melloni, R., Minoja, G.M. et al. Clinical tolerability of ibopamine hydrochloride (SB 7505). Eur J Clin Pharmacol 19, 409–411 (1981). https://doi.org/10.1007/BF00548583

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548583

Key words

Navigation